3M Inadine Dressing

The amber-brown colour of a fresh Inadine dressing comes from the povidone-iodine impregnated into the fabric. As the dressing is in contact with wound fluid, iodine is progressively released and consumed in its antimicrobial action. As the iodine is depleted, the characteristic brown colour fades to white or pale grey. This colour change is a practical and useful clinical signal — when the dressing has turned white, the iodine has been substantially exhausted and antimicrobial activity has ceased. The dressing should be changed at this point and replaced with a fresh Inadine dressing if antimicrobial coverage is still required. Leaving a white (exhausted) Inadine dressing in place provides no antimicrobial benefit and simply acts as a passive dressing.

Iodine plays a fundamental role in thyroid hormone synthesis. In patients with existing thyroid disease — whether overactive, underactive, or autoimmune thyroid conditions — the additional iodine absorbed systemically from povidone-iodine dressings can significantly disrupt the delicate balance of thyroid hormone production. In patients with hyperthyroidism (overactive thyroid), excess iodine can trigger a thyroid crisis (thyroid storm) — a life-threatening emergency. In patients with certain forms of hypothyroidism or Hashimoto's thyroiditis, iodine exposure can worsen the condition. For patients with any thyroid history, the use of iodine-based wound dressings requires specialist medical assessment and should not proceed without explicit clinical authorisation.

Inadine has been used in the management of infected diabetic foot wounds in clinical settings, but diabetic foot wounds represent one of the most complex wound management scenarios and always require multidisciplinary clinical management. Over-the-counter use on a diabetic foot wound without professional assessment is not appropriate. Diabetic foot infections can escalate rapidly, involve deep tissue structures, and carry risks of amputation if not managed correctly. If you are managing a wound on a diabetic foot, seek immediate assessment from a GP, podiatrist, or diabetic foot clinic — do not attempt to self-manage with over-the-counter wound dressings alone.

Yes — Inadine can cause brown or orange staining of the skin and periwound tissue due to iodine contact. This staining is harmless and cosmetic in nature, and will fade over time after the dressing is discontinued. It does not indicate skin damage or allergic reaction. However, significant or worsening redness, swelling, or itching at the wound edge is not staining — it may indicate an allergic reaction or infection, and should prompt clinical assessment.

Yes. Inadine is a primary wound contact dressing that provides antimicrobial coverage directly at the wound surface, but it has limited absorbent capacity on its own. A secondary absorbent dressing — such as a non-woven pad, a foam dressing, or similar — must be applied over the Inadine to manage wound exudate and to hold the primary dressing in place. Without a secondary dressing, the Inadine will not be adequately secured and exudate will not be properly managed, potentially leading to maceration of the periwound skin and reduced dressing effectiveness.

Inadine can be used appropriately in community and home wound care settings when applied by or under the instruction of a trained healthcare professional — such as a community or practice nurse, district nurse, or other wound care-trained clinician. Self-application by a patient or lay carer can be appropriate for straightforward wounds when full instruction has been provided, including guidance on dressing change frequency, how to recognise the colour change indicating dressing exhaustion, and when to seek clinical review. It is not appropriate for members of the public to self-initiate Inadine on wounds without clinical assessment — particularly on wounds of unknown depth, wounds with signs of spreading infection, or in patients with thyroid disease, pregnancy, or other relevant contraindications.